CBPO

China Biologic Products Holdings, Inc.
CBPO

Delisted

CBPO was delisted on the 20th of April, 2021.

18 hedge funds and large institutions have $273M invested in China Biologic Products Holdings, Inc. in 2013 Q2 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
18
Holders Change
+18
Holders Change %
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
18
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
WP
1
Warburg Pincus
New York
$255M 10,989,200 +10,989,200 New
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$4.06M 176,729 +176,729 New
HSBC Holdings
3
HSBC Holdings
United Kingdom
$3.44M 150,000 +150,000 New
BIT
4
BlackRock Institutional Trust
California
$2.56M 110,403 +110,403 New
Invesco
5
Invesco
Georgia
$2.12M 91,413 +91,413 New
Renaissance Technologies
6
Renaissance Technologies
New York
$1.97M 84,800 +84,800 New
VAM
7
Visium Asset Management
New York
$919K 40,003 +40,003 New
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$714K 31,100 +31,100 New
SIM
9
Spark Investment Management
New York
$625K 27,300 +27,300 New
GCP
10
GSA Capital Partners
United Kingdom
$582K 25,093 +25,093 New
PP
11
PDT Partners
New York
$563K 24,531 +24,531 New
Morgan Stanley
12
Morgan Stanley
New York
$530K 22,848 +22,848 New
BA
13
BlackRock Advisors
Delaware
$120K 5,172 +5,172 New
RA
14
Royce & Associates
New York
$67K 2,900 +2,900 New
BJ
15
BlackRock Japan
Japan
$58K 2,492 +2,492 New
TRCT
16
Tower Research Capital (TRC)
New York
$42K 1,794 +1,794 New
OA
17
OFI Advisors
Pennsylvania
$4K 190 +190 New
Citigroup
18
Citigroup
New York
$2K 72 +72 New